Literature DB >> 9435909

Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.

C E Müller1, U Geis, J Hipp, U Schobert, W Frobenius, M Pawłowski, F Suzuki, J Sandoval-Ramírez.   

Abstract

A series of 8-substituted derivatives of 3,7-dimethyl-1-propargylxanthine (DMPX) was synthesized and investigated as A2A adenosine receptor antagonists. Different synthetic strategies for the preparation of DMPX derivatives and analogues were explored. A recently developed synthetic procedure starting from 3-propargyl-5,6-diaminouracil proved to be the method of choice for the preparation of this type of xanthine derivatives. The novel compounds were investigated in radioligand binding studies at the high-affinity adenosine receptor subtypes A1 and A2A and compared with standard A2A adenosine receptor antagonists. Structure-activity relationships were analyzed in detail. 8-Styryl-substituted DMPX derivatives were identified that exhibit high affinity and selectivity for A2A adenosine receptors, including 8-(m-chlorostyryl)-DMPX (CS-DMPX, Ki A2A = 13 nM, 100-fold selective), 8-(m-bromostyryl)-DMPX (BS-DMPX, Ki A2A = 8 nM, 146-fold selective), and 8-(3,4-dimethoxystyryl)-DMPX (Ki A2A = 15 nM, 167-fold selective). These and other novel compounds are superior to the standard A2A adenosine receptor antagonists KF17837 (4) and CSC (5) with respect to A2A affinity and/or selectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435909     DOI: 10.1021/jm970515+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 2.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

3.  Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.

Authors:  Francisco Ciruela; Vicent Casadó; Ricardo J Rodrigues; Rafael Luján; Javier Burgueño; Meritxell Canals; Janusz Borycz; Nelson Rebola; Steven R Goldberg; Josefa Mallol; Antonio Cortés; Enric I Canela; Juan F López-Giménez; Graeme Milligan; Carme Lluis; Rodrigo A Cunha; Sergi Ferré; Rafael Franco
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

4.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats.

Authors:  Marcello Solinas; Sergi Ferré; Katerina Antoniou; Davide Quarta; Zuzana Justinova; Jörg Hockemeyer; Lara A Pappas; Pavan N Segal; Carrie Wertheim; Christa E Müller; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

Review 6.  Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease.

Authors:  Jacobus P Petzer; Neal Castagnoli; Michael A Schwarzschild; Jiang-Fan Chen; Cornelis J Van der Schyf
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

7.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.

Authors:  Anna G Orr; Iris Lo; Heike Schumacher; Kaitlyn Ho; Michael Gill; Weikun Guo; Daniel H Kim; Anthony Knox; Takashi Saito; Takaomi C Saido; Jeffrey Simms; Carlee Toddes; Xin Wang; Gui-Qiu Yu; Lennart Mucke
Journal:  Neurobiol Dis       Date:  2017-10-31       Impact factor: 5.996

Review 8.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388

9.  Microwave-assisted ring closure reactions: synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinediones.

Authors:  Joachim C Burbiel; Jörg Hockemeyer; Christa E Müller
Journal:  Beilstein J Org Chem       Date:  2006-10-27       Impact factor: 2.883

10.  Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease.

Authors:  Faizul Azam; Arwa M Madi; Hamed I Ali
Journal:  J Young Pharm       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.